Technical Articles

In the battlefield of cancer treatment, antibody-drug conjugates (ADC) are gradually emerging and becoming a powerful weapon for precise attack on cancer cells. ADC drugs combine the targeting ability of monoclonal antibodies and the killing ability of potent cytotoxic drugs.